| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |